|10-12-2018 04:51 PM CET - Health & Medicine||
Hospital Acquired Infection Control Market Comprehensive Study 2018 - Roche, Johnson & Johnson,Bayer AG, Olympus Corporation, Medivators, Maquet Getinge Group, Abbott Laboratories, Belimed, MMM Group, Purdue Pharma L.P., And Others
Press release from: Data Bridge Market Research
Hospital Acquired Infection Control Market Report deliver comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the market. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. global Hospital Acquired Infection Control industry 2018-2025 report shares information regarding key drivers, challenges, and Opportunities with its impact by regions. The scope of Hospital Acquired Infection Control Market report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions
Sample PDF Available At databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Hospital Acquired Infection Control Market is expected to reach USD 7.5 billion by 2025, from USD 5.2 billion in 2017 growing at a CAGR of 4.8% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
According to WHO (World Health Organisation), many patients are affected by hospital-acquired infection each year in world which causes major financial and mortality losses for health system. The endemic burden of health care mostly affects the patient in low and middle-income than in high-income countries who are admitted to intensive care units and in neonates.
Market Key Competitors:
• Olympus Corporation,
• Medivators Inc. (Cantel Medical Corp.),
• Getinge Group,
• STERIS Plc.,
• Belimed AG (Metall Zug),
• Steelco S.P.A,
• Pfizer Inc.,
• F. Hoffmann-La Roche Ltd,
• Merck & Co., Inc.,
• Advanced Sterilization Products Services Inc. (Johnson & Johnson),
• Abbott Laboratories,
• Bayer AG,
• Alere Inc.,
• Dickinson and Company,
• Bemis Company,
• Cantel Medical Corp.,
• Covidien plc,
• Crosstex International,Inc.,
• Danaher Corp.,
• Diversey , Inc,
• Getinge Group,
• MMM Group,
• Purdue Pharma LP,
• Sealed Air Corp,
• Semperit AG Holding,
• Synergy Health plc,
Market Competitive Analysis:
The global hospital acquired infection control market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global continuous glucose monitoring market for global, Europe, North America, Asia Pacific and South America.
For Instance, in July 2016, the Getinge Group(Sweden) was acquired by 1stCall Mobility Ltd(U.K.), a company specializing in supplying rental equipment. This acquisition was beneficial for Getinge Group (Sweden) to expand their business strategy.
Speak To Industry Experts, Request For Details Report At databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...
Table Of Contents:
2 Research Methodologies.
3 Executive Summary.
4 Premium Insights.
5 Market Overview.
6 Industry Trends.
7 Compliance in Hospital Acquired Infection Control Market
8 Hospital Acquired Infection Control Market, By Service
9 Hospital Acquired Infection Control Market, By Deployment Type
10 Hospital Acquired Infection Control Market, By Organization Size
11 Hospital Acquired Infection Control Market Analyses, By Vertical
12 Geographic Analyses
• North America
• South America
• Middle East & Africa
13 Competitive Landscapes
14 Detailed Company Profiles
15 Related Reports
Sample TOC Available At databridgemarketresearch.com/toc/?dbmr=global-hospital-ac...
Major Market Drivers and Restraints:
• Increasing prevalence of infections.
• Implementation of stringent guidelines associated with hospital infection prevention and control.
• Developing healthcare infrastructure in emerging countries.
• Rising number of hospitals across the world.
Based on product type, the market is Segmented into:
• microbial testing instruments,
• reagents and consumables,
Based on application, the market is Segmented into:
• disease testing,
• drug-resistance testing.
Based on technology, market is classified into:
• phenotypic methods,
• genotypic methods .
Based on disease, the market is segmented into:
• hospital acquired pneumonia,
• surgical site infections,
• gastrointestinal infections,
• urinary tract infections (uti),
Based on geography, the market report covers data points for 28 countries across multiple geographies namely:
• North America,
• South America,
• Middle East & Africa.
Key Developments in the Market:
• In 2017, STERRAD Systems with ALLClear (U.S.) launched advanced sterilization product STERRAD 100NX ALLClear Technology. This is helpful in minimize workflow interruptions before they occur. It is the only sterilization platform with integrated quality control features, which may enhance compliance.
• In 2014, Kimberly-Clark Health Care (U.S.) and 3M (U.S.) infection prevention division today announced collaboration to deliver best class surgical and infection prevention solutions to hospitals and healthcare facilities in the U.S.
Customization With Discount Available On This Report At databridgemarketresearch.com/inquire-before-buying/?dbmr=...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
News-ID: 1300792 • Views: 599More releases